RUNX3, a remarkable biomarker demonstrated in many solid malignancies, plays a main role of tumor suppression and interacts with other signaling molecules in the context of carcinogenesis in various cancer types including NSCLC [15–23, 15]. This evidence concerns the gene RUNX3 and cancer.